Courier Selection for Clinical Trials
Courier selection is one of the highest-impact decisions in the clinical trial supply chain. A courier determines how reliably, and compliantly investigational product moves through the world — particularly when cold chain, customs clearance or remote sites are involved.
Deciding Between Courier Models
Three broad types of couriers are used in clinical trials:
- Global Express Integrators
- Specialised Logistics Providers
- Hybrid models
It’s rarely “one size fits all”. One courier that works well for a specific study may not be the best solution for all studies. The right choice depends on the risk profile of the study, temperature requirements, lanes and countries.
Cost vs Value
A significant number of courier decisions are based on cost rather than value. If we return to our list of recommended criteria that can be used when selecting a criteria, it is true that the more of these criteria a courier meets, the more expensive their service will be. It is also fair to say that not all criteria apply to every shipment for every clinical trial. For example, having a strong customs brokerage and replenishment/charging network is not required if all shipments for a project are domestic (e.g. intra-US, intra-EU shipments, in-country shipments). Conversely, for a bulk shipment to an overseas depot, which contains a high volume of valuable, temperature sensitive product these features can be critical. Decisions over courier selection must be based on the appropriate balance of cost and requirements.
When to Re-Evaluate Courier Selection
Like any other vendor, Courier performance should be monitored continuously through robust KPIs. In our experience, declining on-time delivery, repeated temperature excursions or customs delays are early indicators that a change may be needed. Mid-study country additions or shifts in recruitment patterns can also justify revisiting the courier mix.
The Outcome
Strong courier selection delivers measurable benefits: fewer delays, higher product integrity, better oversight and lower operational stress. As clinical trial designs become more global and more dependent on temperature-sensitive products, courier capability is increasingly a strategic imperative rather than a commodity.
